|
|
|
The HIV/AIDS epidemic has spread with ferocious speed. Virtually unknown 20 years ago, HIV has infected more
than 60 million people worldwide. Each day, approximately 14,000 new infections occur, more than half of them
among young people below age 25. At the end of 2003, of over 40 million people living with HIV/AIDS (PLWHA),
30 percent were co-infected with tuberculosis (TB). Over 95 percent of PLWHA are in low and middle-income coun
tries. More than 20 million have died from AIDS, 3 million in 2003 alone. AIDS is now the leading cause of death in
Sub-Saharan Africa and the fourth-biggest killer globally. The pharmaceutical industry has already developed and
made 23 HIV medicines available since 1987, and more than 80 new medicines against HIV are in development.
|
 |
| HIV/AIDS Initiatives |
| |
|
Academic Alliance for AIDS Care and Prevention in Africa
Located in Uganda, the first large-scale HIV/AIDS clinic in Africa for training medical personnel on treatment options.
Accelerating Access Initiative (AAI)
A global initiative to broaden access and ensure affordable, safe use of drugs for HIV/AIDS-related illnesses.
African Comprehensive HIV/AIDS Partnership (ACHAP)
Improving prevention, health care access, patient management and treatment of HIV in Botswana.
Abbott Access to HIV Care
Abbott provides its Determine™ HIV rapid test kits and its antiretroviral drugs, Kaletra and Norvir at reduced prices.
PMTCT Donations Program
In 2003 Abbott and Boehringer-Ingelheim announced a cooperative arrangement that will help prevent the transmission of HIV from mother to child.
Cambodia Treatment Access Project
The project specifically aims to increase the access to HIV care, conduct research, and train health-care professionals in Cambodia.
Diflucan Partnership Program
Pfizer provides its antifungal medicine, Diflucan®, to people living with cryptococcal meningitis and/or oesophageal candidiasis.
Enhancing Care Initiative (ECI)
ECI identifies pragmatic, country-led approaches to provide HIV/AIDS care specific to each country's needs and resources. |
|
International
AIDS Vaccine Initiative (IAVI)
IAVI works to ensure the development of safe, effective, accessible HIV vaccines for use throughout the world.
GlaxoSmithKline's Positive Action on HIV/AIDS
Positive Action is GlaxoSmithKline's international program of HIV education, care, and community support.
Infectious Diseases Institute
Training health care professionals in the latest treatment options is an important component in fighting the HIV/AIDS crisis.
Secure the Future
Funded by Bristol-Myers Squibb, this program helps women and children affected by AIDS in sub-Saharan Africa.
Share
This a multi-national program that teaches doctors, healthcare workers, resource planners and public health experts about prevention and management of HIV infection.
Step Forward
In Romania, India, Burkina Faso and Tanzania, Step Forward improves local healthcare, offers HIV counseling and testing, provides clean water and more.
Tanzania Care
To build this country's AIDS response/management system, more than 400 medical professionals are being trained.
VIRAMUNE® Donation Program
VIRAMUNE® is an anti-retroviral drug that reduces the risk of mother-to-child transmission of the HIV virus during labour and delivery. |
|
|
| Initiatives by Region |
| |
 |
| Click on an area of the map to learn about regional health initiatives. |
|
